Listed pharmaceuticals’ sales & management expense ratio continues to decrease

Listed pharmaceutical companies have actively working on cutting their sales & management expenses to increase profitability.

According to the Yakup Shinmoon’s(www.yakup.com) analysis result of the 2016 first half’s reports of KOSPI and KOSDAQ listed pharmaceutical companies, the average ratio of sales & management expenses over sales was 30.1%.

The ratio was decreased from 30.8% compared to ...